Organovo Announces Phase 2 Results For FXR314; Says 'Study Subjects Receiving FXR314 Achieved Statistically Significant Reduction in Liver Fat Content From Baseline'
Organovo 公佈了 FXR314 的第 2 階段結果;表示 “接受 FXR314 的研究受試者肝臟脂肪含量比基準線減少了統計學上的顯著性”
Organovo Announces Phase 2 Results For FXR314; Says 'Study Subjects Receiving FXR314 Achieved Statistically Significant Reduction in Liver Fat Content From Baseline'
Organovo 公佈了 FXR314 的第 2 階段結果;表示 “接受 FXR314 的研究受試者肝臟脂肪含量比基準線減少了統計學上的顯著性”
使用瀏覽器的分享功能,分享給你的好友吧